Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EPGL #1 on Breakout Boards, Huge on Buzz Cloud.
Biotech Train to Pennyland! Welcome.
less than 1.5 hours left to get those 4s. POWER HOUR
Definitely. Power hour is going to be interesting today.
All I know is Valenzano (CEO) himself is converting more than 1/2 of his debt to shares too. That's a signal he's bullish. See the DD above. He even so much as said exactly that.
Thanks post #10362. Also, in 4-27-10 PR they alluded to products to help PTSD in last paragraph. I believe there is one in development based on this.
In their 4-27-10 PR they stated about a PTSD device being developed too. That's where I got that. Look in combined dd at top. it's there.
Hits .001 next week imo
Devices, in the plural. They have devices. PTSD is a whole other FDA device. MPDD is the pain device.
Think about it, multiple FDA devices being developed. This one is just beginning to run.
Dallas is a beautiful city. Love that skyline there. Great place for November's WCD conference. I'll be there.
The MPDD alone is a goldmine. But they have more in development apparently! I don't think a lot of people caught the PTSD reference. That is huge. The US Military has a BIG problem right now with that which needs attention. EPGL and US Military have a good relationship.
I know, name another triple zero with this
This company has more than one FDA device...
The PR's reference to Post Traumatic Stress Disorder (PTSD) suffered by many soldiers right now (EPGL and Military), indicates another device is in development in addition to the MPDD.
From PR:
"Thirdly, the EP Health Sciences Division has multiple projects underway including the development, promotion, and marketing of new FDA approved medical devices..."
EPGL's US Military Connections = MILLIONS $$$$$$$$
Wish I could buy 10M right now.
Buy that 10 million at .0002! :)
BNG can you re-sticky 10121 instead of 10024? You have 10024 in your combined already. Thanks.
CEO Question and Answer #4 with Permission to Post
Q. With the new Health Sciences Division, do you anticipate EPGL will own and market biotech devices and other products?
A. One only has to read the PR headline about our new EP Health Sciences Division for the answer to that question. Nobody should be confused about that. EPGL is moving into significant new areas with the health sciences division. Our mission at EP has always been to help those impacted with disability and pain in all the ways we possibly can. There are many new things in development and announcements will come when it is appropriate to make such things public. Please continue to monitor the news about EPGL in the coming weeks and months ahead. We encourage all shareholders to attend the WCD in person or via the live webcast. You will learn a lot about EP and what it is all about.
-Joe Valenzano, CEO EP Global Communications, EP Health Sciences 9-26-2010
Post #10024 is one everone should read. It is available under news for EPGL. So, can we put #10054 in its place as sticky. I reposted that one for you. Thanks, Iblong.
Giant in the Making? Facts We Know Right Now
1. Restructure Agreement Announced
2. EP Health Sciences Division Opened for Marketing Biotech Devices and Products, working with Dr. Norman Marcus on FDA approved biotech device called MPDD, addressing a market estimated at $85 Billion in size.
3. EPGL announced in April, plans for "exclusive" marketing of MPDD device.
4. CEO Confirmed MPDD device is FDA approved in Q&A posted on this board.
5. CEO Confirmed NO reverse splits or further dilution in Q&A on this board.
6. CEO Confirmed he is taking shares in exchange for debt too in Q&A on this board.
7. CEO Confirmed Health Sciences will own and market biotech devices in question #4 posted on this board.
8. Dr. Norman Marcus scheduled to present MPDD device via worldwide webcast from WCD in Dallas November 17-19. Company tells all shareholders to be in attendance or via webcast.
I agree 100%. If enough people ask moderator to sticky post message #10054 they will put it up top. That is good info everyone should know.
I'd do it soon. It ran to 0024 last year and the news is SO much better now and very promissing.
yes, .002 before November imo. GL
penny stock guru was all over EPGL last week as a gainer over next weeks and months. I saw what BNG is referring to.
Can Moderator Sticky Message #10054? Keep others up too?
They have been known to put things out after hours. All the response said was "sometime today, investors updated". I just email webmaster@eparent.com and usually Joe Valenzano responds or one of their editors. If you are polite, they usually respond pretty fast about IR questions.
I would just ask if they plan to update investors today or not.
PR Update - Emailed Co. Said new investor update coming sometime today. Stay tuned.
This is how biotechnology stars are born. We've seen it before many times. Typically a doctor or scientist invents a new technology and teams with a company which has greater resources and contacts to form a new entity. Dr. Norman Marcus and EP Health Sciences appear to be exactly that.
EPGL is tied in with Allied Health Care Professionals, US Military, and many other health institutions. Dr. Norman Marcus is tied in with New York University and Stephens Institute.
The market the MPDD device addresses enormous and even if it takes a small portion of it, EPGL could be monumentally undervalued right here. I don't think we'll be at .0002 by November's WCD conference when Dr. Marcus makes his presentation to the world.
Great things could happen here.
NEW PR IMMINENT
Emailed company last night to ask if new news is anticipated this week and their PR person said definitely within 24 hours new information will be out. Would not elaborate. Fyi.
I agree. November is the month to watch. They own it or at least are partnered with Dr. Marcus on it. This thing could run to .01 if that news hits. They've thrown many hopeful hints out there. People should read all the sticky posts and PRs by the co. Also, the 4-27-10 PR.
Everybody's waiting for next move. I'm tapped but wish I could buy more of this one. The funny thing is that when it moves up, the ask will be 3 again in a nano-second with volume and everyone could have bought at 2 right here. Who knows?
Yes, here it is. Also, Hanover2 posted it earlier in #10049
http://ih.advfn.com/p.php?pid=nmona&article=42551480&symbol=NO%5EEPGL
Giant in the Making? Facts We Know Right Now
1. Restructure Agreement Announced
2. EP Health Sciences Division Opened for Marketing Biotech Devices and Products, working with Dr. Norman Marcus on FDA approved biotech device called MPDD, addressing a market estimated at $85 Billion in size.
3. EPGL announced in April, plans for "exclusive" marketing of MPDD device.
4. CEO Confirmed MPDD device is FDA approved in Q&A posted on this board.
5. CEO Confirmed NO reverse splits or further dilution in Q&A on this board.
6. CEO Confirmed he is taking shares in exchange for debt too in Q&A on this board.
7. CEO Confirmed Health Sciences will own and market biotech devices in question #4 posted on this board.
8. Dr. Norman Marcus scheduled to present MPDD device via worldwide webcast from WCD in Dallas November 17-19. Company tells all shareholders to be in attendance or via webcast.
Yes, I cannot believe I forgot about that. They have already shown their hand. "exclusive". FDA approved biotech device. .0002 Game on. Get it before sharks come back in and start driving it hard.
Whoa! How Did I Miss This? PR from 4-27-2010
Plans are already underway to help position and market on an exclusive basis an exciting new product with enormous potential for the treatment of back and neck pain for which approximately $86 billion in treatment is spent annually on surgeries, nerve blocks, physical therapy and pain medications." -PR dated 4-27-2010.
Notice the word "exclusive"? In my opinion, they are dropping hints everywhere. If they have an FDA approved device at .0002 this company is a screaming bargain.
Moderator, can we sticky note #10042 ????
The CEO has confirmed there will be no reverse and Health Sciences Division is going to own and market biotech devices. This is very big news and truly a buying opportunity is at hand, imho.
EPGL CEO CONFIRMS BIOTECH INTENTIONS
Q. With the new Health Sciences Division, do you anticipate EPGL will own and market biotech devices and other products?
A. One only has to read the PR headline about our new EP Health Sciences Division for the answer to that question. Nobody should be confused about that. EPGL is moving into significant new areas with the health sciences division. Our mission at EP has always been to help those afflicted with disability and pain in all the ways we possibly can. There are many new things in development and announcements will come when it is appropriate to make such things public. Please continue to monitor the news about EPGL in the coming weeks and months ahead. We encourage all shareholders to attend the WCD in person or via the live webcast. You will learn a lot about EP and what it is all about.
EPGL CEO Q&A Posted with Permission
Q. With the new Health Sciences Division, do you anticipate EPGL will own and market biotech devices and other products?
A. One only has to read the PR headline about our new EP Health Sciences Division for the answer to that question. Nobody should be confused about that. EPGL is moving into significant new areas with the health sciences division. Our mission at EP has always been to help those afflicted with disability and pain in all the ways we possibly can. There are many new things in development and announcements will come when it is appropriate to make such things public. Please continue to monitor the news about EPGL in the coming weeks and months ahead. We encourage all shareholders to attend the WCD in person or via the live webcast. You will learn a lot about EP and what it is all about.
NEW!!! CEO Question and Answer #4 with Permission
Q. With the new Health Sciences Division, do you anticipate EPGL will own and market biotech devices and other products?
A. One only has to read the PR headline about our new EP Health Sciences Division for the answer to that question. Nobody should be confused about that. EPGL is moving into significant new areas with the health sciences division. Our mission at EP has always been to help those impacted with disability and pain in all the ways we possibly can. There are many new things in development and announcements will come when it is appropriate to make such things public. Please continue to monitor the news about EPGL in the coming weeks and months ahead. We encourage all shareholders to attend the WCD in person or via the live webcast. You will learn a lot about EP and what it is all about.
-Joe Valenzano, CEO EP Global Communications, EP Health Sciences 9-26-2010